Page last updated: 2024-10-22

amitriptyline and Hyperkalemia

amitriptyline has been researched along with Hyperkalemia in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Hyperkalemia: Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hutchison, SM1

Other Studies

1 other study available for amitriptyline and Hyperkalemia

ArticleYear
Hyperkalaemia exacerbated by amitryptiline following overdose of potassium-thiazide combination.
    The British journal of clinical practice, 1989, Volume: 43, Issue:6

    Topics: Adult; Amitriptyline; Benzothiadiazines; Diuretics; Humans; Hyperkalemia; Male; Potassium; Sodium Ch

1989